Clinical Trials Directory

Trials / Sponsors / Corestemchemon, Inc.

Corestemchemon, Inc.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
CompletedEvaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS
Amyotrophic Lateral Sclerosis
Phase 12022-11-09
Active Not RecruitingEvaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients with AL
Amyotrophic Lateral Sclerosis
Phase 32021-03-23
CompletedLong-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101)
Multiple System Atrophy
—2018-08-28
CompletedSafety and Tolerability of CS10BR05 Inj. in Subjects with Multiple System Atrophy
Multiple System Atrophy
Phase 12018-04-13
CompletedLong-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis
Lupus Nephritis
—2017-11-29
CompletedEvaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis
Lupus Nephritis
Phase 12017-05-30
CompletedSafety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Scleros
Amyotrophic Lateral Sclerosis, ALS
Phase 1 / Phase 22011-02-01